Ligand Pharmaceuticals Incorporated

GESCHÄFTSMODELL Ligand Pharmaceuticals earns money primarily as a royalty and licensing platform that out-licenses intellectual property (active ingredients, technologies, formulation platforms) to pharmaceutical partners and in return collects milestone payments and revenue shares, without itself conducting capital-intensive clinical development activities.